Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.

[1]  J. Hicks,et al.  Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors , 2008, Modern Pathology.

[2]  K. Miller,et al.  Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder , 2008, Journal of Cancer Research and Clinical Oncology.

[3]  L. Bagella,et al.  Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements , 2008, Journal of cellular physiology.

[4]  Qiang Yu,et al.  Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. , 2007, Genes & development.

[5]  F. Hamdy,et al.  EZH2 promotes proliferation and invasiveness of prostate cancer cells , 2007, The Prostate.

[6]  O. Halvorsen,et al.  EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Liang Cheng,et al.  Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.

[8]  Peter A. Jones,et al.  Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer , 2005, Nature Clinical Practice Urology.

[9]  N. Palavan-Unsal,et al.  Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma , 2005, Urologia Internationalis.

[10]  Yi Zhang,et al.  SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. , 2004, Molecular cell.

[11]  Kristian Helin,et al.  EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.

[12]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Loda,et al.  The EZH2 polycomb transcriptional repressor--a marker or mover of metastatic prostate cancer? , 2002, Cancer cell.

[14]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[15]  C. Meijer,et al.  Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. , 2001, Blood.

[16]  D G Altman,et al.  Statistics Notes: Diagnostic tests 3: receiver operating characteristic plots , 1994, BMJ.

[17]  S. Boorjian,et al.  Increased Expression of the PolycombGroup Gene , EZH 2 , in Transitional Cell Carcinoma of the Bladder , 2005 .